India's apex drug regulatory body, the Central Drugs Standard Control Organisation, has flagged 53 drug samples for failing to meet quality standards.
Pharmaceutical companies including Sun Pharma Laboratories Ltd., Glenmark Pharmaceuticals Ltd., and Alkem Health Science Ltd. are implicated in this quality lapse, NDTV said, quoting CDSCO's August report.